• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症控制——全球视角

Cancer control-A global perspective.

作者信息

Olver I

机构信息

Sansom Institute for Health Research, University of South Australia, Adelaide, SA, 5001, Australia.

出版信息

Eur J Cancer Care (Engl). 2017 Jan;26(1). doi: 10.1111/ecc.12654.

DOI:10.1111/ecc.12654
PMID:28111859
Abstract

Disparities in cancer control exist in low- and middle-income countries (LMICs). Many countries do not have cancer registries to record incidence, mortality and prevalence and are reliant on Globocan estimates of their cancer burden. Poorer cancer control within and between countries occurs in those living remotely from urban centres, those in a low socioeconomic group and some ethnic groups who have lifestyle and belief systems which impact on cancer control. High-income countries generally have population screening programmes for cervix, breast and bowel cancer. However, simpler forms of screening for cancer of the cervix like visual inspection with acetic acid have been shown to be feasible in developing nations. The widespread use of vaccines to prevent cancer has been achieved with the Hepatitis B vaccine but the human papilloma virus vaccine to prevent cancer of the cervix is largely only available in high-income countries. Access to and training of oncological surgeons in LMICs is limited, while 70% of patients in these countries cannot access radiotherapy. The World Health Organization has developed a list of essential medicines although access remains poor in LMICs. The United Nations has set targets for the control of non-communicable diseases to improve global cancer control.

摘要

低收入和中等收入国家(LMICs)在癌症控制方面存在差异。许多国家没有癌症登记处来记录发病率、死亡率和患病率,而是依赖全球癌症负担估计(Globocan)来了解本国的癌症负担情况。在国家内部和国家之间,癌症控制较差的情况出现在居住在远离城市中心的人群、社会经济地位较低的人群以及一些生活方式和信仰体系对癌症控制有影响的族裔群体中。高收入国家通常有针对宫颈癌、乳腺癌和结直肠癌的人群筛查项目。然而,事实证明,在发展中国家,像醋酸目视检查这样更简单的宫颈癌筛查形式是可行的。通过乙肝疫苗已经实现了广泛使用疫苗预防癌症,但预防宫颈癌的人乳头瘤病毒疫苗在很大程度上仅在高收入国家可用。低收入和中等收入国家肿瘤外科医生的获取和培训有限,而这些国家70%的患者无法获得放射治疗。世界卫生组织已经制定了基本药物清单,尽管在低收入和中等收入国家,药物可及性仍然很差。联合国已经设定了控制非传染性疾病的目标,以改善全球癌症控制。

相似文献

1
Cancer control-A global perspective.癌症控制——全球视角
Eur J Cancer Care (Engl). 2017 Jan;26(1). doi: 10.1111/ecc.12654.
2
Expansion of cancer care and control in countries of low and middle income: a call to action.在中低收入国家扩大癌症的防治工作:行动呼吁。
Lancet. 2010 Oct 2;376(9747):1186-93. doi: 10.1016/S0140-6736(10)61152-X. Epub 2010 Aug 13.
3
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.加快低收入和中等收入国家的疫苗及药品获取:变革的理由与优化产品市场授权框架
PLoS One. 2016 Nov 16;11(11):e0166515. doi: 10.1371/journal.pone.0166515. eCollection 2016.
4
Cancer Pain Relief癌症疼痛缓解
5
Improving outcomes in breast cancer for low and middle income countries.改善低收入和中等收入国家乳腺癌的治疗效果。
World J Surg. 2015 Mar;39(3):686-92. doi: 10.1007/s00268-014-2859-6.
6
Breast health in developing countries.发展中国家的乳腺健康。
Climacteric. 2014 Dec;17 Suppl 2:54-9. doi: 10.3109/13697137.2014.947255. Epub 2014 Aug 17.
7
Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020.中低收入国家的放射治疗基础设施和人力资源:现状和 2020 年预测。
Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):448-57. doi: 10.1016/j.ijrobp.2014.03.002. Epub 2014 Apr 18.
8
Can International Patent Law Help Mitigate Cancer Inequity in LMICs?国际专利法能否帮助减轻中低收入国家的癌症不平等现象?
AMA J Ethics. 2020 Feb 1;22(2):E102-111. doi: 10.1001/amajethics.2020.102.
9
The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.扩大治疗和影像学手段的可及性对全球乳腺癌生存差异的影响:基于模拟的分析。
Lancet Oncol. 2021 Sep;22(9):1301-1311. doi: 10.1016/S1470-2045(21)00403-4. Epub 2021 Aug 17.
10
How Should Low- and Middle-Income Countries Motivate Equity in Cancer Prevention and Control?中低收入国家应如何激励癌症预防与控制中的公平性?
AMA J Ethics. 2020 Feb 1;22(2):E147-155. doi: 10.1001/amajethics.2020.147.

引用本文的文献

1
Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus Process.在后 COVID-19 全球背景下重新定义中低收入国家的癌症研究重点:一项经过修正的德尔菲共识过程。
JCO Glob Oncol. 2023 Aug;9:e2300111. doi: 10.1200/GO.23.00111.
2
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.中低收入国家特定基本抗癌药物的可及性、价格和可负担性——以墨西哥为例。
BMC Health Serv Res. 2020 May 14;20(1):424. doi: 10.1186/s12913-020-05167-9.
3
The Difference of Expression of 18 Genes in Axillary Invasion and Vascular Invasion Compared to Control Samples in Breast Cancer.
与乳腺癌对照样本相比,18个基因在腋窝浸润和血管浸润中的表达差异
Iran J Pathol. 2019 Summer;14(3):223-231. doi: 10.30699/ijp.2019.92094.1894. Epub 2019 Aug 1.
4
Access to innovative cancer medicines in a middle-income country - the case of Mexico.中等收入国家获取创新癌症药物——以墨西哥为例。
J Pharm Policy Pract. 2018 Oct 24;11:25. doi: 10.1186/s40545-018-0153-y. eCollection 2018.